Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
C 8.20 0.06% 0.01
BHC closed unchanged on Wednesday, November 20, 2024, on 44 percent of normal volume. It ran into resistance at its 50 day moving average. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.06%
Oversold Stochastic Weakness 0.06%
Fell Below 50 DMA Bearish 0.06%
Stochastic Reached Oversold Weakness 0.06%
Down 3 Days in a Row Weakness 0.06%
Down 4 Days in a Row Weakness 0.06%
Down 5 Days in a Row Weakness 0.06%
Gapped Down Weakness 0.06%
Oversold Stochastic Weakness 0.06%
Narrow Range Bar Range Contraction -2.21%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bausch Health Companies Inc. Description

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Life Sciences Organ Systems Laser Eye Pharmaceutical Products Gastrointestinal Medical Device S&P/Tsx 60 Index Health Products Dermatology Psoriasis Specialty Drugs Ulcerative Colitis Gastroenterology Ulcer Atopic Dermatitis Colitis Acne Dermatitis Contact Lens Diarrhea Irritable Bowel Syndrome Generic Pharmaceutical Wrinkle Generic Pharmaceuticals Hair Removal Over The Counter Products Actinic Keratosis Keratosis

Is BHC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.46
52 Week Low 3.96
Average Volume 2,041,200
200-Day Moving Average 7.72
50-Day Moving Average 8.30
20-Day Moving Average 8.81
10-Day Moving Average 8.80
Average True Range 0.29
RSI (14) 41.86
ADX 28.01
+DI 23.00
-DI 30.52
Chandelier Exit (Long, 3 ATRs) 8.97
Chandelier Exit (Short, 3 ATRs) 8.87
Upper Bollinger Bands 9.99
Lower Bollinger Band 7.63
Percent B (%b) 0.24
BandWidth 26.76
MACD Line 0.06
MACD Signal Line 0.23
MACD Histogram -0.1677
Fundamentals Value
Market Cap 2.99 Billion
Num Shares 365 Million
EPS -2.65
Price-to-Earnings (P/E) Ratio -3.09
Price-to-Sales 0.35
Price-to-Book 18.78
PEG Ratio 0.63
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.49
Resistance 3 (R3) 8.51 8.44 8.44
Resistance 2 (R2) 8.44 8.36 8.43 8.42
Resistance 1 (R1) 8.31 8.31 8.29 8.29 8.41
Pivot Point 8.24 8.24 8.23 8.23 8.24
Support 1 (S1) 8.11 8.16 8.09 8.09 7.97
Support 2 (S2) 8.04 8.11 8.03 7.96
Support 3 (S3) 7.91 8.04 7.94
Support 4 (S4) 7.89